FDG-PET and beyond: Molecular breast cancer imaging

被引:120
作者
Quon, A [1 ]
Gambhir, SS [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Radiol, Div Nucl Med,Mol Imaging Program, Stanford, CA 94305 USA
关键词
D O I
10.1200/JCO.2005.11.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1664 / 1673
页数:10
相关论文
共 58 条
[1]   Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET [J].
Adler, LP ;
Faulhaber, PF ;
Schnur, KC ;
AlKasi, NL ;
Shenk, RR .
RADIOLOGY, 1997, 203 (02) :323-327
[2]   EVALUATION OF BREAST MASSES AND AXILLARY LYMPH-NODES WITH [F-18] 2-DEOXY-2-FLUORO-D-GLUCOSE PET [J].
ADLER, LP ;
CROWE, JP ;
ALKAISI, NK ;
SUNSHINE, JL .
RADIOLOGY, 1993, 187 (03) :743-750
[3]   Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations [J].
Avril, N ;
Rosé, CA ;
Schelling, M ;
Dose, J ;
Kuhn, W ;
Bense, S ;
Weber, W ;
Ziegler, S ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3495-3502
[4]  
Bassa P, 1996, J NUCL MED, V37, P931
[5]   Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) [J].
Bellon, JR ;
Livingston, RB ;
Eubank, WB ;
Gralow, JR ;
Ellis, GK ;
Dunnwald, LK ;
Mankoff, DA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04) :407-410
[6]  
Bernstein V, 2000, J NUCL MED, V41, p289P
[7]   Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].
Bos, R ;
van der Hoeven, JJM ;
van der Wall, E ;
van der Groep, P ;
van Diest, PJ ;
Comans, EFI ;
Joshi, U ;
Semenza, GL ;
Hoekstra, OS ;
Lammertsma, AA ;
Molthoff, CFM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387
[8]   Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):: A feasibility study [J].
Ciernik, IF ;
Dizendorf, E ;
Baumert, BG ;
Reiner, B ;
Burger, C ;
Davis, JB ;
Lütolf, UM ;
Steinert, HC ;
Von Schulthess, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03) :853-863
[9]  
Crippa F, 1998, J NUCL MED, V39, P4
[10]   Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy [J].
Dehdashti, F ;
Flanagan, FL ;
Mortimer, JE ;
Katzenellenbogen, JA ;
Welch, MJ ;
Siegel, BA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (01) :51-56